Trials / Completed
CompletedNCT05646056
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
A Noninterventional, Single-Center Feasibility Study to Evaluate Longitudinal Measures of Heart Failure Risk Using the Pyxida System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Prolaio · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Software | Observation only |
Timeline
- Start date
- 2022-10-28
- Primary completion
- 2024-09-18
- Completion
- 2024-09-18
- First posted
- 2022-12-12
- Last updated
- 2024-10-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05646056. Inclusion in this directory is not an endorsement.